Eltrombopag in Good’s Syndrome
Good’s syndrome is a rare acquired immunodeficiency associated with thymoma. Eltrombopag is a thrombopoietin receptor agonist and has been shown to be a valuable supplement to the treatment of several types of refractory cytopenias. In this paper, we describe a male patient suffering from Good’s syn...
Saved in:
Main Authors: | Håvard Anton Kristiansen, Signe Spetalen, Yngvar Fløisand, Dag Heldal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2014/172139 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aplastic Anemia Treated with Eltrombopag during Pregnancy
by: Yuri Suminaga, et al.
Published: (2022-01-01) -
Eltrombopag Improves Refractory Thrombocytopenia in a Patient with Systemic Lupus Erythematosus
by: Natsuki Shima, et al.
Published: (2018-01-01) -
Malignant Phyllodes Tumor and Acute Megakaryoblastic Leukemia Sharing a Common Clonal Origin
by: Yngvar Fløisand, et al.
Published: (2013-01-01) -
The Effectiveness of Rapamycin Combined with Eltrombopag in Murine Models of Immune-Mediated Bone Marrow Failure
by: Shaoxue Ding, et al.
Published: (2020-01-01) -
Simultaneous Manifestation of Chronic Myelomonocytic Leukemia and Multiple Myeloma during Treatment by Prednisolone and Eltrombopag for Immune-Mediated Thrombocytopenic Purpura
by: Masao Hagihara, et al.
Published: (2016-01-01)